Advicenne: Likozam to be Reimbursed Starting June 2026, Claims €6M from the State
Advicenne, a specialty pharmaceutical group, announced on Monday that Likozam (clobazam) will be covered by the French social security system starting June 12, 2026. This decision concludes the early access program and simplifies the group's financial structure.
A Decision that Concludes the Early Access Program
The publication of the reimbursement decision in the Official Journal allows the distribution of Likozam in retail pharmacies. The set price of €92.24, tax included, for the 150 ml presentation ends the so-called 'early access' (AAP) mechanism, which required Advicenne to return up to 80% of the revenues generated by the product. This system complicated the financial transparency of the group by making it difficult to interpret commercial data.
A Significant Reduction in Debt
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The obtained reimbursement price creates a claim of approximately €6 million from the French state. This claim offsets a substantial portion of the group's debt to the government, incurred under the early access program. Advicenne will also record a reversal of provisions of about €1.4 million related to the closure of the program. The group emphasizes that this automatic debt reduction is a major factor in its ongoing financial restructuring.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
